Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 3601: Discovery of novel dual-acting KRASG12C inhibitors that target both the active and inactive forms of the protein

Cancer Res (2022) 82 (12_Supplement): 3601.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal